Showing results (411-420 of 420) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 420 results.
The Journal of Allergy and Clinical Immunology|June 15, 2024
Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunityMartin C Runnstrom, Pedro A Lamothe, Caterina E Faliti, et al.
The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trialMarcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.
The New England Journal of Medicine|March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorHilary Longhurst, Marco Cicardi, Timothy Craig, et al.
Nature Microbiology|September 24, 2024
Pathogen genomic surveillance status among lower resource settings in AsiaMarya Getchell, Suci Wulandari, Ruklanthi de Alwis, et al.
Cell Reports|May 29, 2026
Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gapsWan Ni Chia, Feng Zhu, Samuel Mo Sheng Cheng, et al.
The Journal of Clinical Investigation|February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Wellcome Open Research|September 16, 2024
Large-scale exome array summary statistics resources for glycemic traits to aid effector gene prioritizationSara M Willems, Natasha H J Ng, Juan Fernandez, et al.
Pageof 42